Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Operating Leases (2019 - 2025)

Veracyte's Operating Leases history spans 7 years, with the latest figure at $40.5 million for Q3 2025.

  • For Q3 2025, Operating Leases rose 226.23% year-over-year to $40.5 million; the TTM value through Sep 2025 reached $40.5 million, up 226.23%, while the annual FY2024 figure was $43.2 million, 474.58% up from the prior year.
  • Operating Leases for Q3 2025 was $40.5 million at Veracyte, down from $50.6 million in the prior quarter.
  • Across five years, Operating Leases topped out at $50.6 million in Q2 2025 and bottomed at $7.5 million in Q4 2023.
  • The 5-year median for Operating Leases is $14.9 million (2023), against an average of $21.4 million.
  • The largest annual shift saw Operating Leases dropped 29.33% in 2023 before it soared 474.58% in 2024.
  • A 5-year view of Operating Leases shows it stood at $14.1 million in 2021, then dropped by 24.46% to $10.6 million in 2022, then decreased by 29.33% to $7.5 million in 2023, then skyrocketed by 474.58% to $43.2 million in 2024, then decreased by 6.44% to $40.5 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Operating Leases are $40.5 million (Q3 2025), $50.6 million (Q2 2025), and $50.5 million (Q1 2025).